CPC SCIENTIFIC ARTICLES & INSIGHTS
View our latest articles and resources on peptides, oligonucleotides, CDMO innovation and pharma trends, and more.
Mar 31, 2026
CPC Scientific had a fantastic time connecting with partners, clients, and colleagues this year at DCAT Week 2026. See our highlights from New York, featuring generic API scale-up, the 98th DCAT Annual Dinner, and more...
Mar 27, 2026
Catch CPC Scientific's key moments from NextGen Biomed 2026, where we showcased how our advanced process design is accelerating production timelines and cost efficiency for greener TIDES manufacturing at scale...
Dec 17, 2025
From our group's IPO milestone to CDMO thought leadership, 2025 marked meaningful progress at CPC Scientific. Explore featured resources from the year and see how our people, partners, and platforms drove impact throughout 2025.
Dec 15, 2025
President Theresa Cheng spoke to PhD students at Weill Cornell Graduate School, sharing industry insights and exploring how academic research today can translate into tomorrow’s cutting-edge healthcare leadership...
Nov 7, 2025
From Nusinersen to Inclisiran, oligonucleotide APIs are rapidly reshaping modern drug development. Explore the role of oligonucleotide CDMOs in enabling analytical innovation and scalable, compliant manufacturing across the RNA therapeutic frontier.
Oct 31, 2025
Peptide and oligonucleotide APIs are driving a new generation of pharmaceutical drug development. Learn more about the API manufacturing process and why it matters to partner with a specialized peptide and oligonucleotide CDMO.
Oct 28, 2025
CPC Scientific is thrilled to return to CPHI Frankfurt 2025! Explore our booth as we recap key moments from Day 1 of CPHI, where we're highlighting our position as a globally pioneering peptide & oligo CDMO...
Oct 22, 2025
In today’s biotech landscape, quality is essential. For therapeutics based on peptides or oligonucleotides, many of which treat complex or life-threatening conditions, GMP compliance is a foundational element of regulatory approval and patient trust.
Oct 15, 2025
At CPC Scientific, we know that peptide programs rarely move in a straight line. That’s why our FTE services are designed to provide dedicated scientific support, supplementing your team with our CRDMO manufacturing expertise and facilities...
Oct 7, 2025
Selecting the right partner can directly impact both speed-to-market and long-term commercial success, particularly for peptide and oligo programs. A CDMO addresses this by providing support across the drug development lifecycle.
Sep 24, 2025
Peptide–oligo conjugates are innovative hybrid molecules uniting the targeting precision of peptides with the gene-modulating power of oligos. However, harnessing their potential requires overcoming significant technical barriers...
Sep 17, 2025
CPC Scientific is back at Boulder Peptide Symposium 2025 as a Gold Sponsor! Discover key moments from the symposium and see how our team is pioneering innovations in large-scale peptide synthesis...